Literature DB >> 33984156

Pregnant women report being denied medications to treat severe nausea and vomiting of pregnancy or hyperemesis gravidarum - findings from an Australian online survey.

Han-Fang Hsiao1, Alicia Thomas1, Caitlin Kay-Smith2, Luke E Grzeskowiak1,3,4,5.   

Abstract

We conducted an online survey of 249 Australian women who currently or previously experienced severe nausea and vomiting of pregnancy (NVP) or hyperemesis gravidarum (HG) and examined their experiences in being denied medications during pregnancy. One in four women reported being denied medications for NVP/HG, which most commonly involved doxylamine and encounters with community pharmacists. Women's experiences reflected that lack of awareness of guidelines and unfavourable risk-benefit assessments appeared to be key barriers to facilitating medication access. Approaches towards identifying and effectively addressing barriers to the provision of effective treatments for severe NVP and HG are urgently needed.
© 2021 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Australia; antiemetics; community survey; hyperemesis gravidarum; morning sickness; pregnancy

Year:  2021        PMID: 33984156     DOI: 10.1111/ajo.13359

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  1 in total

1.  Assessment of management approaches for hyperemesis gravidarum and nausea and vomiting of pregnancy: a retrospective questionnaire analysis.

Authors:  Rachel Mares; Adelene Morrow; Haley Shumway; Isain Zapata; David Forstein; Benjamin Brooks
Journal:  BMC Pregnancy Childbirth       Date:  2022-08-01       Impact factor: 3.105

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.